Ae Wealth Management LLC Sorrento Therapeutics, Inc. Transaction History

Ae Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$0.74 - $1.83 $370 - $915	-500 Reduced 3.65%	13,207 $11,000
Q3 2022 Oct 25, 2022	BUY	$1.51 - $2.88 $48 - $92	32 Added 0.23%	13,707 $22,000
Q2 2022 Aug 03, 2022	SELL	$1.24 - $2.33 $124 - $233	-100 Reduced 0.73%	13,675 $27,000
Q1 2022 Apr 18, 2022	BUY	$2.0 - $4.9 $2,438 - $5,973	1,219 Added 9.71%	13,775 $32,000
Q4 2021 Jan 20, 2022	SELL	$4.65 - $7.23 $9,788 - $15,219	-2,105 Reduced 14.36%	12,556 $58,000
Q3 2021 Nov 01, 2021	BUY	$7.41 - $10.99 $15,753 - $23,364	2,126 Added 16.96%	14,661 $112,000
Q2 2021 Jul 21, 2021	BUY	$6.35 - $10.0 $79,597 - $125,350	12,535 New	12,535 $121,000

5.53M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.